Yet further examples of exendin analogs suitable for use in the engineered polypeptide constructs are those described in published PCT application WO/2010/ ...

[0065] Further examples of exendin analogs suitable for use in the engineered polypeptide constructs are those described in published PCT application ...

The present application relates to compounds having good duration of action, high potency and/or convenient dosing regimens, including oral administration, ...

... Application filed by AstraZeneca Pharmaceuticals LP filed Critical ... solution Substances 0.000 description 15; 108020004414 DNA Proteins 0.000 ...

6,806,063 is said with U.S. Patent application No.20080261886. On the one hand, the present invention provides the monomers B PXTEN fusion rotein of FIX, ...

The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of non-small cell lung cancer and ...

Moreover, in therapeutic applications of monoclonal antibodies, it is important to identify antibodies having a high degree of specificity and a high binding ...

... SDS or with 0.2×SSC/0.1% SDS. In some embodiments, a GPCR that may be ... kit manufacturer's instructions. The fluorescence ratio of the samples (test ...

[2] The instant application relates to use of myostatin pathway inhibitors and GLP-1 pathway activators for treating and maintaining metabolic disorders, ...

... window, where the fragment of the polynucleotide or amino acid sequence in the comparison window may comprise additions or deletions (e.g., gaps or ...

... (Gila monster)和墨西哥鬃狮蜥(Mexican Bearded Lizard)的唾液分泌物中发现的肽 ... SDS的凝胶运行缓冲液中电洗脱。如果GST/工程改造的多肽的融合蛋白在细菌中作为 ...